Dr. Rahimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8525Fax+1 214-645-8526
Education & Training
- University of Virginia Medical CenterResidency, Radiation Oncology, 2007 - 2011
- University of Virginia Medical CenterInternship, Internal Medicine, 2006 - 2007
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2006
- Finch University of Health SciencesM.S., Applied Physiology, 2001 - 2002
- University of California San Diego (UCSD)B.S., Biochemistry, 1997 - 2001
Certifications & Licensure
- TX State Medical License 2011 - 2026
- VA State Medical License 2006 - 2011
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Educator of The Year ARRO, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Resident UVA Teaching Award 2011
- Join now to see all
Clinical Trials
- Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer Start of enrollment: 2010 Oct 04
- Ixabepilone and SBRT For Metastatic Breast Cancer Start of enrollment: 2013 Aug 01
- HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 31 citationsOutcomes of Patients With Head-and-Neck Cancer of Unknown Primary Origin Treated With Intensity-Modulated RadiotherapyA. Shoushtari, Drew K. Saylor, Kara-Lynne Kerr, Ke Sheng, Christopher Y. Thomas
International Journal of Radiation Oncology, Biology, Physics. 2011-11-01 - 108 citationsCarbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/Repair.Osama Mohamad, Brock J. Sishc, Janapriya Saha, Arnold Pompos, Asal Rahimi
Cancers. 2017-06-09 - 44 citationsPreliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast IrradiationAsal Rahimi, Kimberly Thomas, Ann Spangler, Roshni Rao, Marilyn Leitch
International Journal of Radiation Oncology, Biology, Physics. 2017-05-01
Journal Articles
- Electronic Medical Record�Based Radiation Oncology Toxicity, Recording Instrument Aids Benchmarking and Quality Improvement in the ClinicAlbuquerque K, Rodgers K, Spangler A, Rahimi A, Willett D, Journal of Oncology Practice, 1/1/2018
- Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiationZhen X, Zhao B, Wang A, Timmerman R, Spangler A, Kim N, Rahimi A, Gu X, Radiation Oncology, 1/1/2017
- Constructing a Clinicopathologic Prognostic Modelfor Triple Negative Breast Cancer (TNBC)Thomas K, Shiao J, Rao R, Leitch M, Spangler A, Wooldridge R, Rivers A, Kim N, Rahimi A, American Journal of Hematology Oncology, 1/1/2017
- Join now to see all
Abstracts/Posters
- Phase I dose escalation trial using single fraction Stereotactic PBI for early stage breast cancerRahimi A, Kim N, Spangler A, Leitch M, Alluri P, Gu X, Ahn C, Goudreau S, Seiler S, Farr D, Wooldridge R, Haley B, Bahrami S, Chen D, Rao R, Timmerman R, ESTRO Conference, Milan, Italy, 4/2019
- Novel Hyaluronan Formulation for Preventing Acute Skin Reactions in Breast during Radiotherapy: A Randomized Clinical TrialO Mohamad, K Albuquerque, DW Nathan Kim, D Chen, K Thomas, R Wooldridge, A Rivers, M Leitch, R Rao, B Haley, C Ahn, D Garwood, A Spangler, A Rahimi, ASTRO, San Antonio, TX, 10/2018
- Long-Term Results of a Prospective Pilot Safety and Feasibility Study of Adjuvant Concurrent Capecitabine and External Beam Irradiation Demonstrates Tolerability and E...D Vo, A Rahimi, J O'shaughnessy, ASpangler, J Li, B Haley, M Leitch, R Rao, C Osborne, J Wu, D Garwood, D Tripathy, H Choy, D. Na Kim, ASTRO, San Diego, CA, 9/2017
- Join now to see all
Lectures
- Altered Fractionation in Partial Breast Radiation - Plenary Breast sessionACRO, Orlando, FL - 3/2019
- Your Challenges Today- Our Solutions TomorrowASTRO, San Antonio, TX - 10/2018
- Breast Cancer and RisksPilates Methodology, Dallas, TX - 10/2018
- Join now to see all
Press Mentions
- New Radiation Technology for Breast Cancer PatientsApril 25th, 2019
- UTSW’s GammaPod Makes Breast Cancer Treatment More PreciseApril 11th, 2019
- After Breast Cancer, How Pilates Can Aid RecoveryOctober 1st, 2018
- Join now to see all
Grant Support
- Phase I Dose Escalation Trial Using Stereotactic Body Radiation Therapy (SBRT) For Partial Breast Irradation (PBI)- 1 fractionAccuray2017–Present
- Phase I Dose Escalation Trial Using Stereotactic Body Radiation Therapy (SBRT) For Partial Breast Irradation (PBI)- 5 fractionAccuray2015–Present
- Randomized, Double –Blind, Vehicle-Controlled Pilot Study of the Efficacy and Safety of Hylacare TM in the Treatment of Acute Skin Changes in Patients Undergoing EBRT for Tumors of the BreastHylacare2014–2015
Professional Memberships
- Member
- Member
Other Languages
- Farsi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: